| Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial K Shitara, M Özgüroğlu, YJ Bang, M Di Bartolomeo, M Mandalà, MH Ryu, ... The Lancet 392 (10142), 123-133, 2018 | 1136 | 2018 |
| BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial B Bockorny, V Semenisty, T Macarulla, E Borazanci, BM Wolpin, ... Nature Medicine 26 (6), 878-885, 2020 | 354 | 2020 |
| Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis K Hur, P Cejas, J Feliu, J Moreno-Rubio, E Burgos, CR Boland, A Goel Gut 63 (4), 635-646, 2014 | 309 | 2014 |
| Classification of anticancer drugs—a new system based on therapeutic targets E Espinosa, P Zamora, J Feliu, MG Barón Cancer treatment reviews 29 (6), 515-523, 2003 | 271 | 2003 |
| Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry J Lopez-Sendon, C Alvarez-Ortega, P Zamora Auñon, A Buño Soto, ... European heart journal 41 (18), 1720-1729, 2020 | 215 | 2020 |
| KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis P Cejas, M Lopez-Gomez, C Aguayo, R Madero, J de Castro Carpeno, ... PloS one 4 (12), e8199, 2009 | 196 | 2009 |
| Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study J Feliu, P Escudero, F Llosa, M Bolaños, JM Vicent, A Yubero, ... Journal of clinical oncology 23 (13), 3104-3111, 2005 | 160 | 2005 |
| Clinical relevance of colorectal cancer molecular subtypes N Rodriguez-Salas, G Dominguez, R Barderas, M Mendiola, ... Critical reviews in oncology/hematology 109, 9-19, 2017 | 156 | 2017 |
| XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer J Feliu, A Salud, P Escudero, L Lopez-Gómez, M Bolanos, A Galán, ... British Journal of Cancer 94 (7), 969-975, 2006 | 153 | 2006 |
| Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer E Espinosa, J Feliu, P Zamora, MG Barón, JJ Sanchez, A Ordonez, ... Lung cancer 12 (1-2), 67-76, 1995 | 153 | 1995 |
| A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy R Sánchez-Martínez, S Cruz-Gil, MG de Cedrón, M Álvarez-Fernández, ... Oncotarget 6 (36), 38719, 2015 | 146 | 2015 |
| Management of pancreatic cancer in the elderly O Higuera, I Ghanem, R Nasimi, I Prieto, L Koren, J Feliu World journal of gastroenterology 22 (2), 764, 2016 | 145 | 2016 |
| Symptom clusters in advanced cancer A Jiménez, R Madero, A Alonso, V Martínez-Marín, Y Vilches, B Martínez, ... Journal of pain and symptom management 42 (1), 24-31, 2011 | 139 | 2011 |
| Usefulness of megestrol acetate in cancer cachexia and anorexia: a placebo-controlled study J Feliu, M Gonzalez-Baron, A Berrocal, A Artal, A Ordonez, P Garrido, ... American journal of clinical oncology 15 (5), 436-440, 1992 | 137 | 1992 |
| Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: beyond KRAS mutations A Custodio, J Feliu Critical reviews in oncology/hematology 85 (1), 45-81, 2013 | 134 | 2013 |
| Longitudinal study of cognitive dysfunctions induced by adjuvant chemotherapy in colon cancer patients JA Cruzado, S López-Santiago, V Martínez-Marín, G José-Moreno, ... Supportive Care in Cancer 22, 1815-1823, 2014 | 119 | 2014 |
| Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles P Cejas, L Li, NK O'Neill, M Duarte, P Rao, M Bowden, CW Zhou, ... Nature medicine 22 (6), 685-691, 2016 | 115 | 2016 |
| Cardiac toxicity: old and new issues in anti-cancer drugs M Sereno, A Brunello, A Chiappori, J Barriuso, E Casado, C Belda, ... Clinical and Translational Oncology 10, 35-46, 2008 | 103 | 2008 |
| Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study M Gonzalez-Baron, J Feliu, I De la Gandara, E Espinosa, A Colmenarejo, ... European Journal of Cancer 31 (13-14), 2215-2219, 1995 | 103 | 1995 |
| Development and validation of a prognostic nomogram for terminally ill cancer patients J Feliu, AM Jiménez-Gordo, R Madero, JR Rodríguez-Aizcorbe, ... Journal of the National Cancer Institute 103 (21), 1613-1620, 2011 | 101 | 2011 |
